Author: administrator

• Product

  • Cables
  • Leads
• Application
  • Pacemakers
  • Defibrillators
  • EEG
  • ECG
• End User
  • Cables and Leads for Medical Equipment at Hospitals
  • Cables and Leads for Medical Equipment at Ambulatory Care Centers
  • Cables and Leads for Medical Equipment at Academic Research Institutes
  • Cables and Leads for Medical Equipment at Specialty Clinics

A recent study by Fact.MR on the cables and leads for medical equipment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates recent market developments, strategic market growth analysis, market size, category market growths, product approvals, product launches, geographical expansions, and technological innovations associated with cables and leads for medical equipment.

The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies manufacturing cables and leads for medical equipment, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of cables and leads for medical equipment across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of cables and leads for medical equipment during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for cables and leads for medical equipment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report.

Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global cables and leads for medical equipment market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the cables and leads for medical equipment market during the forecast period.

Country-specific valuation on demand for cables and leads for medical equipment has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Competition Analysis

The report sheds light on leading manufacturers of cables and leads for medical equipment, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering cables and leads for medical equipment has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the cables and leads for medical equipment market.

Key Takeaways from Market Study

• Global cables and leads for medical equipment market to top US$ 6 Bn by 2031.
• ECG equipment projected to reach around US$ 2.7 Bn by 2031.
• Pacemakers projected to record around 2.9% CAGR over the next 10 years.
• ECG equipment projected to reach around US$ 2 Bn by 2031.
• Market in Japan to record 1.2% CAGR over the forecast period 2021- 2031.
• China forecast to reach projected market size above US$ 1.3 Bn by 2031.
• Market in Canada projected to expand at above 3% CAGR over next 10 years.

“Increasing adoption of newer and innovative monitoring devices in medical & healthcare applications expected to boost demand for cables and leads for medical equipment,” says a Fact.MR analyst.           

Market Competition

Rising environmental concerns have increased focus on the creation of ecofriendly cables and leads for medical equipment.

• Nikomed USA recently introduced BioWire, a non-metallic disposable and universal lead wire system that is recyclable. These leads are easily disposable and can be incinerated without the need for extra processing or preparation.

Increasing number of players are now focused on providing products with better efficiency and lower risk rates.

• Transplant Pathogen Monitoring Test Kits
  • CMV PCR Kits
  • EBV PCR Kits
  • BKV PCR Kits
  • Aspergillus Test Kits
  • Multiplex PCR Kits
• Transplant Pathogen Monitoring by Sample
  • Blood Serum Sample Transplant Pathogen Monitoring
  • Plasma Sample Transplant Pathogen Monitoring
  • Swabs Sample Transplant Pathogen Monitoring
  • Urine Sample Transplant Pathogen Monitoring
• Distribution Channel
  • Hospitals
  • Diagnostic Laboratories
  • Cancer Research Institutes
  • Specialty Centers

A recent market study published by Fact.MR on the market offers industry analysis for 2016-2020 & an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics.

On conducting thorough research on the historical as well as current growth parameters of the transplant pathogen monitoring market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the transplant pathogen monitoring market during the forecast period. It can help market players in strategizing their manufacturing and marketing strategies to envisage maximum growth in the transplant pathogen monitoring market in the coming years.

Adoption of transplant pathogen monitoring is set to witness a rise due to increasing prevalence of chronic diseases and subsequent organ failure. The test related to transplant pathogen monitoring allows successful assessment of the feasibility of procedures involving transplantation. Increasing innovation in technologies related to pathogen monitoring for the management of transplant procedures as well as infection-related scenarios has led to wide adoption of transplant pathogen monitoring by healthcare providers.

Rising geriatric population and presence of chronic diseases in the age group above 60 years are leading to frequent incidence of post-transplant infections (22.7%), as compared to younger transplant recipients (3.3%), as per a 2019 study in the U.S. population for kidney transplant patients.

Key Takeaways from Market Study

• Despite restricted growth amid COVID-19, demand for transplant pathogen monitoring is expected to rise at nearly 6.7% CAGR through 2031.
• Increasing focus on infection and control is driving a transition towards transplant pathogen monitoring.
• The U.S. will account for a dominant share of 65.7% over the forecast period.
• Argentina is the fastest-growing market in Latin America, exhibiting a 7% CAGR through 2031.

“High incidence of post-transplantation infections in the elderly and advancements in technology for transplant pathogen monitoring have led to an increase in the growth opportunity for market players,” says a FACT.MR analyst.

Increasing Focus on Innovation to Offer Growth Opportunities

Rising number of soft tissues, stem-cell-based, and solid transplantation procedures have led to an augmentation in laboratory automation of transplant pathogen monitoring. In addition, growing advancements in human leukocyte antigen typing have further assisted growth of the transplant pathogen monitoring market.

Increasing public and private investments to develop innovative products for testing and development & enhancement of healthcare infrastructure have assured a rise in the adoption of transplant pathogen monitoring.

• Type
  • Single Donors of Human Umbilical Vein Endothelial Cells
  • Pooled Donors of Human Umbilical Vein Endothelial Cells
• Application
  • Human Umbilical Vein Endothelial Cells for Wound Healing
  • Human Umbilical Vein Endothelial Cells for Angiogenesis
  • Human Umbilical Vein Endothelial Cells for Tissue Engineering
  • Human Umbilical Vein Endothelial Cells for Inflammation Treatment
  • Human Umbilical Vein Endothelial Cells for Oncology
  • Human Umbilical Vein Endothelial Cells for Other Applications
• Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Russia
    •  Nordics
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Turkey
    • Rest of MEA

A recent study by Fact.MR on the human umbilical vein endothelial cells (HUVEC) market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering human umbilical vein endothelial cells.

The study also provides the dynamics responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the HUVEC market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of human umbilical vein endothelial cells across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of HUVEC during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Market estimates at global and regional levels for human umbilical vein endothelial cells are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global HUVEC market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the HUVEC market during the forecast period.

Country-specific valuation on demand for human umbilical vein endothelial cells has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

In-depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of human umbilical vein endothelial cells, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering human umbilical vein endothelial cells has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Key Takeaways from Market Study

• By type, pooled donor-derived HUVECs are expected to experience elevated sales through 2031
• Oncology to emerge as a highly promising application area for HUVEC-based treatment
• The U.S. to generate multiple revenue streams for the market, across CVD treatment, oncology, and angiogenesis
• Extensive development of biotechnology and cell culture studies driving demand across India

Fact.MR’s study on the hydrosurgery systems market offers information divided into three important segments-component type, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Component Type

• System Console
• Handpiece
• Accessories

Application

• Chronic Wounds
• Surgical Wounds
• Traumatic Wounds
• Burn Cases

End User

• Hospitals
• Clinics
• Ambulatory Surgical Centres
• Homecare Settings

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Fact.MR recently published a market study on the global market for hydrosurgery systems. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the hydrosurgery systems market structure. The market study presents exclusive information about how the hydrosurgery systems market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include year-on-year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the hydrosurgery systems market during the forecast period.

The study is relevant for stakeholders in the hydrosurgery systems market, including, manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the hydrosurgery systems market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.

Key Takeaways from Hydrosurgery Systems Market Study

• COVID-19 will greatly influence the growth trajectory of the market. Ubiquitous lockdown of public and private sector industries is bringing down the number of trauma cases caused by industrial burns. This is significantly hampering demand for hydrosurgery.
• A large number of companies manufacturing handheld Hydrosurgery Systems contributed to a significant chunk of market share in terms of revenue in the hydrosurgery systems market.
• North America and Europe collectively hold over 50% of the hydrosurgery systems market share owing to new product launches in these regions.
• In terms of end user, hospitals are expected to dominate the hydrosurgery systems market during the forecast period.
• The hydrosurgery systems market is highly fragmented. Some of the prominent manufacturers include Smith & Nephew plc. HydroCision Inc, Erbe Elektromedizin GmbH. and few others.

“Technological advancements leading to the introduction of new and advanced products and emergence of number of players in the market have intensified Hydrosurgery Systems sales,” says a Fact.MR analyst.    

Rising Prevalence of Chronic Wounds to Boost Demand for Hydrosurgery Systems

Chronic wounds are the major public health burden worldwide. The growing prevalence of diabetes, ulcers, obesity, and metabolic syndrome make chronic wounds a social, economic and clinical challenge.

According to the American Professional Wound Care Association, the chronic ulcers are estimated to cost the health care system $28 billion each year in United States, as a primary diagnosis and up to $31.7 billion as secondary diagnosis.

There is also a profound psychological impact on the patients suffering from chronic wounds, such as loneliness, depression and separation from an active social life. Hydrosurgery systems will witness a sharp uptake after the COVID-19 spread is contained. The rising prevalence of chronic wounds is expected to increase the risk of cancer and favor the growth of the hydrosurgery systems market over the forecast period.

Fact.MR has studied the global cardiopulmonary stress testing systems market with detailed segmentation on the basis of product, end-user and region.

Product

• Cardiopulmonary Exercise Testing (CPET) Systems
• Stress ECG
• Pulse Oximeters
• Stress Blood Pressure Monitors
• Single-photon Emission Computed Tomography (SPECT)

End-user

• Hospitals
• Specialty Clinics/Cardiology Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

The recent study by Fact.MR on the global cardiopulmonary stress testing systems market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of the global cardiopulmonary stress testing systems market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with the manufacturing of cardiopulmonary stress testing system devices. The study also provides dynamics that are responsible for influencing the future status of the global cardiopulmonary stress testing systems market over the forecast period.

A detailed assessment of the global cardiopulmonary stress testing systems market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the global cardiopulmonary stress testing systems market along with their product portfolio enhances the reliability of this comprehensive research study.

Global Cardiopulmonary Stress Testing Systems Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global cardiopulmonary stress testing systems market across the globe.

A comprehensive estimate of the global cardiopulmonary stress testing systems market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of the global cardiopulmonary stress testing system device during the forecast period. Price point comparison by region with the global average price is also considered in the study.

Global Cardiopulmonary Stress Testing Systems Market: Analysis on Market Size Evaluation

The global cardiopulmonary stress testing systems market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for the Cardiopulmonary stress testing systems market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent cardiopulmonary stress testing systems market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Cardiopulmonary Stress Testing Systems Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global cardiopulmonary stress testing systems market report, which have helped deliver projections on regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global cardiopulmonary stress testing systems market during the forecast period.

Country-specific valuation on demand for cardiopulmonary stress testing systems has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Global Cardiopulmonary Stress Testing Systems Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of the global cardiopulmonary stress testing systems drugs market along with their detailed profiles. Essential and up-to-date data and information related to the market performers, who are principally engaged in the production of cardiopulmonary stress testing systems devices, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permit the report readers to take preemptive steps in advancing their businesses.

Key Takeaways of Global Cardiopulmonary Stress Testing Services Market Study:

• By product type, the cardiopulmonary exercise testing (CPET) system shall capture more than half of the total cardiopulmonary stress testing services market. This is attributed to its distinct advantage of providing a reliable measurement of a patient’s functional capacity. This enables practitioners to accurately determine the prognosis of heart diseases.
• Stress ECGs are anticipated to soar in popularity amid soaring infection rates of COVID-19 and given the increasing market penetration of key manufacturers such as Koninklijke Philips N.V, GE Healthcare and Schiller AG. These companies manufacture devices such as the DXL 16-Lead ECG Algorithm, the CASE Exercise Testing System and the CARDIOVIT AT-180 High-performance 16-channel ECG system. The segment shall capture nearly 1/5th of the global cardiopulmonary stress testing systems market, expanding 1.3x during the forecast period.
• By end-user, the diagnostic test centers segment shall expand rapidly, owing to increasing number of medical procedures at outpatient settings in highly populated countries. Moreover, affordability of treatment and availability of post-procedure consultation are other growth drivers. The segment is anticipated to grow at a CAGR of 5.2% during the forecast period.
• By region, North America shall account for the lion’s share in the global cardiopulmonary stress testing systems market, capturing one-third of the overall market. With North America currently being the epicenter of COVID-19 crisis, sales are further set to soar. Increasing hospitalization rates and rising efficiency in accurate diagnostics of cardiovascular diseases are anticipated to leverage the market.
• Asia-Pacific shall emerge as the most lucrative region, attributable to deeper market penetration by key players and increased awareness about stress testing. A CAGR of 5.4% is predicted for the Asia-Pacific cardiopulmonary stress testing systems market. The anticipated market share is pegged at over one-fourth.
• Key manufacturers are anticipated to witness an upsurge in their production capabilities, owing to favorable government regulations to combat the COVID-19 pandemic. For instance, the US FDA has provided clearance to utilize extracorporeal membrane oxygenation (ECMO) and cardiopulmonary devices in increased capacity. It is anticipated that using ECMO reduces chances of complications among heart patients.

“The global cardiopulmonary stress testing systems market shows an upward trajectory. Rising prevalence of CVDs and ongoing COVID-19 pandemic has prompted manufacturers to introduce more efficient cardiopulmonary stress testing systems through consistent innovations in their product pipeline,” concludes a Fact.MR analyst.